BioCentury | Jun 27, 2019
Distillery Therapeutics

An insulin-conjugated dual SLC2A1/SLC2A4 inhibitor for diabetes

...DISEASE CATEGORY: Endocrine/metabolic INDICATION: Diabetes A team led by Zenomics Inc. scientific co-founder Zhen Gu identified an...
...glucose transporter member 1 (SLC2A1) (GLUT1) Solute carrier family 2 facilitated glucose transporter member 4 (SLC2A4) (GLUT4) Diabetes Zenomics Inc....
Items per page:
1 - 1 of 1
BioCentury | Jun 27, 2019
Distillery Therapeutics

An insulin-conjugated dual SLC2A1/SLC2A4 inhibitor for diabetes

...DISEASE CATEGORY: Endocrine/metabolic INDICATION: Diabetes A team led by Zenomics Inc. scientific co-founder Zhen Gu identified an...
...glucose transporter member 1 (SLC2A1) (GLUT1) Solute carrier family 2 facilitated glucose transporter member 4 (SLC2A4) (GLUT4) Diabetes Zenomics Inc....
Items per page:
1 - 1 of 1